CTOs on the Move

Privis Health

www.privishealth.com

 
Privis Health is a leading provider of innovative data-driven population health programs and technology rich services that enable healthcare providers to deliver high quality efficient care to their patient population. Our scalable, cloud-based platform empowers healthcare providers to better manage risk, while achieving their operating and performance goals as they transition from fee-for-service to value based reimbursement. In addition, we assist with the design, implementation and expansion of population health programs, while sharing in the accountability for the success of these initiatives. The Privis team has deep experience with a programmatic approach to provide strategies on service models, organizational transformation, ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.privishealth.com
  • 2000 Aerial Center Parkway Suite 107
    Morrisville, NC USA 27560
  • Phone: 888.533.9490

Executives

Name Title Contact Details

Similar Companies

Chartered Health Plan/DC HealthCare Alliance

Chartered Health Plan/DC HealthCare Alliance is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Familymeds Group Inc

Familymeds Group Inc is a Farmington, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BlueDot

Toronto-based digital health firm BlueDot, has developed a first-of-its-kind, global early warning technology for infectious diseases. Using artificial and human intelligence, BlueDot`s outbreak risk platform tracks over 150 infectious diseases globally in 65 languages, around the clock and anticipates their spread and impact. They empower national and international health agencies, hospitals, and businesses to better anticipate, and respond to, emerging threats.

New England Employee Benefits Co. INC

New England Employee Benefits Co. INC is a Concord, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sarepta

Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare diseases. Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in Limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth (CMT) and CNS-related disorders, reaching a total of over 20 therapies in various stages of development. The Company`s programs span across several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is poised to be the most meaningful precision genetic medicine company in the world and make a profound difference in the lives of patients suffering from rare neuromuscular diseases and other rare diseases.